Chronic hepatitis C treatment in HIV co‐infection in Portugal: Results from a cohort OF 2133 patients presented by GEPCOI (Portuguese Coinfection Study Group)

Direct‐acting antiviral drugs (DAAs) have recently changed the paradigm of hepatitis C therapy, significantly improving treatment response rates, patient life expectancy and quality of life. In Portugal, sofosbuvir (SOF) and SOF/ledipasvir (SOF/LDV) were fully reimbursed by the National Health Syste...

Descripción completa

Detalles Bibliográficos
Autores principales: Miranda, Ana Cláudia, Mendez, Josefina, Serrão, Rosário, Vale, Francisco, Manata, Maria José, Pinto, Sara, Gomes, André, Valente, Cristina, Pacheco, Patrícia, Pazos, Rosário, Pereira, Rui, Martins, Ana, Germano, Isabel, Rocha, Sónia, Reis, Ana Paula, Sarmento‐Castro, Rui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7317188/
https://www.ncbi.nlm.nih.gov/pubmed/32096268
http://dx.doi.org/10.1111/jvh.13281

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7317188/
https://www.ncbi.nlm.nih.gov/pubmed/32096268
http://dx.doi.org/10.1111/jvh.13281

Ejemplares similares